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Background: Granulicatella spp. is a fastidious bacteria responsible for bacteremia and endocarditis which are fatal
in about 20% of the cases. These severe infections are uncommon in children under 17 years of age and have
proven extremely difficult to treat.
Cases presentation: We report a brief review of the literature and two cases of NVS bacteremia by Granulicatella
complicated by infective endocarditis (IE). The first one is that of a 7-year-old Caucasian female with Shone
syndrome and IE involving the pulmonary valve homograft, confirmed by echocardiography. The second case is
that of a 5-year-old Caucasian male. In this patient echocardiogram was negative for signs of IE; however, a
“possible” IE was suspected on the basis of a cardiac catheterization 3 weeks before the onset of fever. Since in
both our patients clinical failure of first line antibiotic treatment was observed, we used a combination of
meropenem with another anti-streptococcal drug with excellent results.
Conclusion: In Granulicatella bacteremia in the pediatric population, combination antimicrobial therapy including
meropenem should be considered as a second line treatment in non-responding patients.
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Granulicatella is a fastidious Gram-positive nutritionally
variant streptococcus (NVS) that is classified in two differ-
ent genera: Abiotrophia which includes only A. defectiva
and the genus Granulicatella which comprises three spe-
cies (G. adiacens, G. elegans and G. balaenopterae). Since
these organisms require pyridoxal or thiol group supple-
mentation for growth, their isolation may be difficult.
Granulicatella spp is part of the normal flora of the oral
cavity, the genitourinary tract, and the intestinal tract. Al-
though NVS are found as part of normal flora of the upper
respiratory, urogenital, and gastrointestinal tracts, their
ability to cause clinically significant disease has been in-
creasingly recognized. The most frequent clinical syn-
dromes caused by NVS are endocarditis and bacteraemia
[1] but these microorganisms have been implicated also in
several others infections such as central nervous system* Correspondence: maiadeluca@gmail.com
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reproduction in any medium, provided the orinfections [2], sinusitis, otitis media, prostatitis, cholangitis,
arthritis [3]. In vivo and in vitro antimicrobial susceptibility
tests suggest that peniclillin plus aminoglycoside or vanco-
mycin alone should be considered as therapeutically
equivalent [4], although antibiotic resistance has been de-
scribed for both these drugs [5,6].
IE is uncommon in children under 17 years of age, but
it is a cause of significant morbidity. Notably, 90% of IE
cases occur in individuals who have structural heart dis-
ease, usually congenital. However, even children with
normal hearts, could be at risk of IE due to invasive
procedures such as bronchoscopy, tonsillectomy etc. [7].
The clinical presentation of IE is usually indolent with
prolonged low grade fever associated with non-specific
symptoms such as myalgia, arthralgia, headache and
generalize malaise whilst classical signs of IE (e.g. Roth
spots, Osler nodes) are very rare in children [8]. Mortal-
ity rate ranges from 4% to 18% and complications in-
clude valvular insufficiency, congestive heart failure,
embolization, mycotic aneurism, etc. Cardiovascular sur-
gery may be life-saving in these patients, but decision for
surgical intervention must be individualized [7,8].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cases of bacterial endocarditis in the adult population
[4] and carry a worse prognosis compared to infection
with other streptococci [9]. In patients with endocarditis
caused by Granulicatella, classic endocarditis signs such
as digital clubbing, Osler nodes and petechiae are rare.
Pre-existing valvular pathology is a frequent predispos-
ing factor. Because of the difficulties in isolating this or-
ganism its role as a pathogen in endocarditis could be
underestimated. Consequently, some cases of culture-
negative endocarditis could be attributed to this micro-
organism [2].
Here, we report two cases of paediatric NVS bacter-
aemia, one of which with confirmed heart localization
and review of the literature.
Case presentation N.1
The first case concerns a 7-year-old Caucasian female
with Shone syndrome (characterized by coartation of
aorta, mitral stenosis and subvalvular aortic stenosis). At
the age of 1 month she underwent a coartectomy and 6
years later she underwent a Ross-Konno procedure (aortic
valve replacement with a pulmonary autograft and pul-
monary valve replacement with a homograft conduit) plus
mitral valvuloplasty. The last echocardiogram, performed
1 month before admission to our hospital, showed a sub-
total obstruction of the conduit.
She was admitted to our hospital with a history of 2-
weeks of nocturnal fever, treated at home with ceftriax-
one without success. The patient appeared acutely ill;
clinical examination revealed a 2-3/6 systolic murmur
and hepatosplenomegaly. A complete blood count re-
vealed anemia (Hb 10.3 g/dl), white blood cells count
15,760/ml with 84.2% neutrophils and 11.7% lympho-
cytes, CRP 4.86 mg/dl. Transthoracic echocardiogram
was negative for signs of IE. The child had fever to 39°C.
Vancomycin and gentamicin were started, with subse-
quent defervescence. Blood samples were taken for cul-
tures. After 4 days of therapy, fever recurred and was
associated with shaking chills. Gram-positive cocci in
short chains were isolated from blood cultures, but there
was very scant growth on routine bacterial culture
media. Applied Biosystems 3130 and 3130xl Genetic An-
alyzers identified the organism as G. adiacens. Antibiotic
susceptibility tests (AST) were not available. A repeat
echocardiogram demostrated a filamentous (10 × 2 mm)
on the homograft. Antibiotic therapy was changed to
vancomycin plus meropenem.
After four weeks, therapy was switched to oral amoxi-
cillin and clavulanic acid. The patient began to complain
of right-side abdominal and chest pain. Suspecting pul-
monary embolism, a lung computer tomography scan
was performed. This revealed a pyramid-shaped area of
pleural-based consolidation in the posterior segment ofthe right lower lobe. No significant filling defects of the
pulmonary arteries and their major branches were evident.
Intravenous treatment with vancomycin plus meropenem
was restarted and continued for additional two weeks; low
molecular weight heparin was prescribed. However, due to
a persistent dysfunction of the conduct, it was replaced
with a pulmonary valved homograft. Cultures of prosthetic
material were negative. Six months later the patient was
doing well and had negative blood cultures.
Case presentation N.2
A 5-year-old Caucasian male was brought to our hos-
pital with a 2-month history of fever and associated
diarrhoea and leg pain. His past medical history was sig-
nificant for infundibular pulmonary stenosis. Cardiac
catheterization had been performed 3 weeks before the
onset of fever. At admission, he presented general mal-
aise, asthenia, anorexia, pale skin and a systolic murmur.
Laboratory tests revealed a white blood count of 8,370/
ml with 70% neutrophils and CRP 2.99 mg/dl. Blood
cultures were obtained and empiric antibiotic treatment
with cefotaxime and gentamicin was started. Transtho-
racic and transesophageal echocardiograms revealed no
vegetations and chest x-ray and abdominal ultrasound
were negative. Two blood cultures taken 24 hours apart
isolated G. Adiacens, susceptible to cephalosporins, vanco-
mycin, tetracycline, cloramphenicol, linezolid and resistant
to penicillin. Despite antimicrobial therapy, the patient’s
fever persisted and five days after admission two blood
cultures were again positive for G. adiacens that was now
resistant to beta-lactams, tetracycline, cloramphenicol,
linezolid, susceptible to vancomycin, clindamycin and
levofloxacin (MIC 1.5 mcg/ml, 0.125 mcg/ml and 0.38
mcg/ml respectively). Meropenem was not tested. Therapy
was changed to ciprofloxacin (10 mg/kg q12) and
meropenem (30 mg/kg q8). Repeated transthoracic and
transesophageal echocardiograms were again unchanged
from the patient’s baseline; nonetheless, these findings led
us to consider the patient to have “possible” infective
endocarditis according to modified Duke criteria (the pa-
tient fulfilled three minor criteria: fever, predisposing heart
condition, microbiological evidence) [10].
Defervescence was observed after one week of treatment
and inflammatory markers normalized. Three blood cul-
tures were sterile. Therapy was continued for a total of
four weeks.
At a follow-up visit 6 months after discontinuation of
therapy, the patient was doing well and had sterile blood
cultures.
Review of the literature
A review of the literature on endocarditis due to
Granulicatella spp was performed by a PubMed search
for the period between 1997 and 2011 using the
Table 1 Case reports of Granulicatella spp. Endocarditis described in the literature
Author Age
(years)











/ None Positive / Yes Yes Pi + T and G then
added V
/ No Relapse
Heath et al. (1998) 45 G.
adiacens
M None Positive Positive
(Transesophageal)
No / P + G(4 weeks) then P
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F Artificial aortic valve
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prosthesis

























M Bicuspit aortic valve Negative Positive (both
transthoracic and
transesophageal)





M None Positive Positive Yes No Ce + G 4 weeks No relapse




M Mitral regurgitation Positive Negative
(transthoracic)







F None Positive / Yes Yes P + G 4 weeks No relapse
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M Mitral valve prolapse Positive Positive (both
transthoracic and
transesophageal
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Positive Negative / / Ce then P + G 6 weeks Relapse 6 weeks
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M None Positive Positive
(transthoracic)
Yes No Ox + G / No relapse























Table 1 Case reports of Granulicatella spp. Endocarditis described in the literature (Continued)
Lin CH et al. 2007 18 G.
adiacens
F None Positive Positive / Yes P + G / No relapse
Lin CH et al. 2007 61 G.
adiacens
M None Positive Positive / Yes P + G / No relapse
Lin CH et al. 2007 30 G.
adiacens
M None Positive Positive / Yes P + G + Cx / No relapse
Lin CH et al. 2007 28 G.
adiacens
F None Positive Positive / Yes P + G then V and then
Te
/ No relapse
Laho D et al. 2011 81 G.
adiacens




No No Ap + G Ap (4 weeks) G (2
weeks)
No relapse
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Abiotrophia defectiva, nutritionally variant Streptococci. A
study was considered eligible for inclusion in the review if
it reported data on the localization of the disease, isolation
of the bacterium, antibiotic treatment (type and, in some
cases, duration), and outcome of patients. Our search
identified 16 relevant articles, describing a total of 20 pa-
tients (fourteen men, five women, one unspecified), with
mean age of 47 years (Table 1). The analysis of clinical as-
pects of these patients revealed that nine had risk factors
for IE (such as structural heart disease, recent cardiac sur-
gical procedures), echocardiography was negative for signs
of endocarditis in two patient, peripheral stigmata of
endocarditis were absent in six and unknown in five. Re-
garding the treatment, beta-lactam plus gentamicin was
the empiric therapeutic regimen in 18/20 patients; in two
cases even rifampin was used in the treatment of attack.
The treatment duration varied (from 2 to 6 weeks) (in
seven cases treatment data were not available). Combined
surgical and medical treatment was undertaken in eight
patients and in two cases there were relapse after discon-
tinuation of therapy. Christensen et al. [11] reported 3
pediatric cases with IE due to Granulicatella spp.
Conclusions
We reported two cases of Granulicatella bacteremia and
IE. Endocarditis involving the valve homograft was dem-
onstrated in one by echocardiography and was strongly
suspected in the second case. Both patients failed first
line antibiotics, but subsequently responded to a second
line regimen including meropenem.
In the adult population, NVS endocarditis has a higher
mortality rate (17%), then IE caused by enterococci (9%) or
viridans streptococci (0-12%) [12]. It is not clear if mortal-
ity is similarly increased in the pediatric population.
NVS endocarditis may be extremely difficult to treat.
In particular, treatment of Abiotrophia/Granulicatella
infection is complicated by variable susceptibility to com-
monly used antistreptococcal antibiotics, such as penicillin
and ceftriaxone, as well as significant resistance to mac-
rolides [13,14]. Vancomycin demonstrates susceptibility
in vitro, while gentamicin and rifampicin may be useful
for synergy [13]. Nevertheless, treatment failure was ob-
served in about 41% of the cases, despite sensitivity of the
organisms to the antibiotics used in two-thirds of these
cases [12], and almost 27% of reported cases required
prosthetic valve replacement [15]. Moreover, the optimal
duration of treatment has not been elucidated.
Since in both our patients failed first line antibiotic treat-
ment was observed, we used a combination of meropenem
with another anti-streptococcal drug, based on previous re-
ports suggesting up to 96% of strains may be susceptible to
meropenem [16,17]. To our knowledge this is the first de-
scription of Granulicatella spp bacteraemia successfullytreated with a combination therapy including meropenem.
Blood cultures quickly became sterile and surgical therapy
was not required (conduit obstruction observed in the first
case was not clearly a direct consequence of IE, since pre-
vious dysfunction had been documented and cultures of
the excised graft were sterile). AST of serial isolates from
the first patient was obtained and it showed unexpected re-
sults. The initial blood culture isolate had the expected pat-
terns of antibiotic sensibility. However, a second isolate,
obtained after 5 days of treatment was resistant to cephalo-
sporins, tetracycline, chloramphenicol and linezolid and
the MIC for vancomycin had increased to 1.5 mcg/ml, a
concentration that may predict a poor in vivo response. Of
note, to our knowledge this is the first report of a strain of
Granulicatella adiacens that is resistant to linezolid.
In conclusion, in Granulicatella IE in the pediatric
population, a combination antibiotic regimen including
meropenem should be considered as second line treat-
ment in patients who fail to respond to conventional
recommendations. Finally, pediatricians should be aware
of the possibility of Granulicatella bacteremia and IE in
little patients with structural heart disease or prosthetic
cardiac valves and those undergoing cardiac procedures.
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